ATE257837T1 - Neuartige ester abgeleitet von substituierten phenyl-zyklohexyl-verbindungen - Google Patents

Neuartige ester abgeleitet von substituierten phenyl-zyklohexyl-verbindungen

Info

Publication number
ATE257837T1
ATE257837T1 AT02075837T AT02075837T ATE257837T1 AT E257837 T1 ATE257837 T1 AT E257837T1 AT 02075837 T AT02075837 T AT 02075837T AT 02075837 T AT02075837 T AT 02075837T AT E257837 T1 ATE257837 T1 AT E257837T1
Authority
AT
Austria
Prior art keywords
cyklohexyl
compounds
substituted phenyl
esters derived
novel esters
Prior art date
Application number
AT02075837T
Other languages
English (en)
Inventor
Castillo Nieto Juan Carlos Del
Freixa Maria Chalaux
Clotet Joan Huguet
Mancini Marisabel Mourelle
Ramon Amat Elisabet De
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Application granted granted Critical
Publication of ATE257837T1 publication Critical patent/ATE257837T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02075837T 1998-11-06 1999-11-04 Neuartige ester abgeleitet von substituierten phenyl-zyklohexyl-verbindungen ATE257837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009802329A ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
PCT/ES1999/000352 WO2000027799A1 (es) 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos

Publications (1)

Publication Number Publication Date
ATE257837T1 true ATE257837T1 (de) 2004-01-15

Family

ID=8305698

Family Applications (3)

Application Number Title Priority Date Filing Date
AT99953994T ATE249418T1 (de) 1998-11-06 1999-11-04 Neuartige ester abgeleitet von substituierten phenyl-cyclohexyl-verbindungen
AT02075838T ATE257817T1 (de) 1998-11-06 1999-11-04 Neuartige ester abgeleitet von substituierten phenyl-zyklohexyl-verbindungen
AT02075837T ATE257837T1 (de) 1998-11-06 1999-11-04 Neuartige ester abgeleitet von substituierten phenyl-zyklohexyl-verbindungen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT99953994T ATE249418T1 (de) 1998-11-06 1999-11-04 Neuartige ester abgeleitet von substituierten phenyl-cyclohexyl-verbindungen
AT02075838T ATE257817T1 (de) 1998-11-06 1999-11-04 Neuartige ester abgeleitet von substituierten phenyl-zyklohexyl-verbindungen

Country Status (39)

Country Link
US (1) US6455585B1 (de)
EP (3) EP1219623B1 (de)
JP (1) JP2002529442A (de)
KR (1) KR100453613B1 (de)
CN (1) CN1176902C (de)
AP (1) AP1222A (de)
AT (3) ATE249418T1 (de)
AU (1) AU755681B2 (de)
BG (1) BG105556A (de)
BR (1) BR9915727A (de)
CA (1) CA2349245A1 (de)
CR (1) CR6368A (de)
CU (1) CU23006A3 (de)
CZ (1) CZ20011500A3 (de)
DE (3) DE69914231T2 (de)
DK (3) DK1127871T3 (de)
EA (1) EA003742B1 (de)
EE (1) EE200100246A (de)
ES (4) ES2141688B1 (de)
GE (1) GEP20033116B (de)
HR (1) HRP20010412B1 (de)
HU (1) HUP0104218A3 (de)
ID (1) ID29017A (de)
IL (1) IL142592A0 (de)
IS (1) IS5934A (de)
MA (1) MA26765A1 (de)
MX (1) MXPA01004432A (de)
NO (1) NO20012234L (de)
NZ (1) NZ511739A (de)
OA (1) OA11672A (de)
PL (1) PL347492A1 (de)
PT (3) PT1127871E (de)
SI (3) SI1127871T1 (de)
SK (1) SK284068B6 (de)
TR (3) TR200200416T2 (de)
UA (1) UA59477C2 (de)
WO (1) WO2000027799A1 (de)
YU (1) YU29601A (de)
ZA (1) ZA200104026B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
AU2003264311A1 (en) * 2002-08-28 2004-04-08 Jin Wang Oral formulations of ibuprofen and tramadol, methods and preparation thereof
DE50312678D1 (de) 2002-11-22 2010-06-10 Gruenenthal Gmbh Verwendung von (1R, 2R)-3-(3-Dimenthylamino-1-ethyl-2-methyl-propyl)-phenol zur Behandlung von Entzündungsschmerz
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
ES2599031T3 (es) 2008-05-09 2017-01-31 Grünenthal GmbH Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
BR112012001466A2 (pt) 2009-07-22 2020-08-11 Grünenthal GmbH forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
ES2534908T3 (es) 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
EP2383255A1 (de) 2010-04-28 2011-11-02 Lacer, S.A. Neue Verbindungen, deren Synthese und Verwendung bei der Schmerzbehandlung
WO2012028318A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
EP2530072A1 (de) 2011-06-03 2012-12-05 Lacer, S.A. Neue Verbindungen, deren Synthese und Verwendung bei der Schmerzbehandlung
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
JP6063462B2 (ja) 2011-07-29 2017-01-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
BR112014019988A8 (pt) 2012-02-28 2017-07-11 Gruenenthal Gmbh Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
LT2838512T (lt) 2012-04-18 2018-11-12 Grünenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US9339484B2 (en) * 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
HK1224189A1 (zh) 2013-11-26 2017-08-18 Grünenthal GmbH 通过低温研磨制备粉状药物组合物
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
DK1219623T3 (da) 2004-04-19
EE200100246A (et) 2002-12-16
DK1127871T3 (da) 2003-11-24
NO20012234D0 (no) 2001-05-04
CA2349245A1 (en) 2000-05-18
BG105556A (en) 2001-12-29
SK284068B6 (sk) 2004-09-08
ES2141688B1 (es) 2001-02-01
ZA200104026B (en) 2002-05-17
NZ511739A (en) 2002-11-26
EP1127871A1 (de) 2001-08-29
SI1219594T1 (en) 2004-06-30
CN1325377A (zh) 2001-12-05
ATE257817T1 (de) 2004-01-15
ES2141688A1 (es) 2000-05-16
YU29601A (sh) 2003-04-30
PL347492A1 (en) 2002-04-08
KR100453613B1 (ko) 2004-10-20
DE69911235T2 (de) 2004-07-01
DE69914231T2 (de) 2004-11-11
ES2213731T3 (es) 2004-09-01
IL142592A0 (en) 2002-03-10
PT1127871E (pt) 2003-12-31
EA200100476A1 (ru) 2002-02-28
CU23006A3 (es) 2004-12-17
WO2000027799A1 (es) 2000-05-18
GEP20033116B (en) 2003-11-25
DK1219594T3 (da) 2004-04-19
ID29017A (id) 2001-07-26
KR20010080942A (ko) 2001-08-25
TR200200415T2 (tr) 2002-06-21
NO20012234L (no) 2001-05-04
BR9915727A (pt) 2001-09-04
SK5842001A3 (en) 2001-12-03
SI1219623T1 (en) 2004-06-30
HUP0104218A2 (hu) 2002-03-28
CR6368A (es) 2002-04-08
ATE249418T1 (de) 2003-09-15
PT1219594E (pt) 2004-04-30
OA11672A (en) 2005-01-12
CN1176902C (zh) 2004-11-24
DE69914229D1 (de) 2004-02-19
DE69911235D1 (de) 2003-10-16
JP2002529442A (ja) 2002-09-10
ES2207298T3 (es) 2004-05-16
EP1219594B1 (de) 2004-01-14
US6455585B1 (en) 2002-09-24
HRP20010412A2 (en) 2002-12-31
SI1127871T1 (en) 2004-02-29
MXPA01004432A (es) 2002-09-18
CZ20011500A3 (cs) 2001-09-12
PT1219623E (pt) 2004-04-30
DE69914231D1 (de) 2004-02-19
HRP20010412B1 (en) 2004-04-30
UA59477C2 (uk) 2003-09-15
MA26765A1 (fr) 2004-12-20
EP1219623B1 (de) 2004-01-14
IS5934A (is) 2001-05-03
EP1219623A1 (de) 2002-07-03
ES2213732T3 (es) 2004-09-01
EP1127871B1 (de) 2003-09-10
TR200101160T2 (tr) 2002-01-21
AP1222A (en) 2003-11-06
AU1047300A (en) 2000-05-29
TR200200416T2 (tr) 2003-01-21
AU755681B2 (en) 2002-12-19
EP1219594A1 (de) 2002-07-03
EA003742B1 (ru) 2003-08-28
HUP0104218A3 (en) 2002-11-28
DE69914229T2 (de) 2004-12-09

Similar Documents

Publication Publication Date Title
ATE249418T1 (de) Neuartige ester abgeleitet von substituierten phenyl-cyclohexyl-verbindungen
ID22013A (id) Senyawa-senyawa ester
ID22095A (id) Asam aril-akrilat ester
DE69818942D1 (de) Stanolester enthaltende Zusammensetzungen
DE69827330D1 (de) Stanolester enthaltende Zusammensetzung
EE200000573A (et) Asendatud indoolalkaanhapped
ID15886A (id) Pembuatan alkil ester secara kontiniu dari asam met-akrilik
DE69900144D1 (de) Celluloseesterzusammensetzung
DE59700915D1 (de) Stabilisierter Milchsäurementhylester
ID15885A (id) Pembuatan alkil ester secara kontiniu dari asam met-akrilik
ID24863A (id) Proses pembuatan vinil ester dari butenoligomeran
DE69728978D1 (de) Kälteerzeugungsöl enthaltend ester von gehinderten alkoholen
ID20656A (id) Ko-produksi ester
NO983969D0 (no) Lavtsmeltende esterkvats
NO991561L (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
ID21536A (id) Pembuatan ester
BR9610022A (pt) Esteres
DE69707251D1 (de) Maleimidobenzosäure Ester
DE59904496D1 (de) Enzymatische veresterung
ATE242761T1 (de) Phenyl-methoxyimino-glyoxylsäureester-derivate als pestizide
ID22727A (id) Senyawa ester
ID27852A (id) Sintesis ester
ATE221519T1 (de) Ester von 3-hydroxy-piperidinmethanol-derivaten
FI953519A7 (fi) Uudet substituoidut tiosemikarbatsonihappoesterit
DE69529285D1 (de) Stabilisierte Acrylsäurezusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1219623

Country of ref document: EP

REN Ceased due to non-payment of the annual fee